| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/01/2004 | CN1524879A Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof |
| 09/01/2004 | CN1524877A Construction and preparation of stroma cell derivative factor - 1ª‡ recombinant mutant |
| 09/01/2004 | CN1524874A E1A protein, its preparing process and combination of medicament comprising the protein |
| 09/01/2004 | CN1524869A Method for extracting anticarcinogenesis polysaccharide composite AVDS from A.valvataD. and its use as medicament |
| 09/01/2004 | CN1524857A Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 09/01/2004 | CN1524583A Use of gene for expressing Notch-ligand in production of medicinal preparations for immunotherapy |
| 09/01/2004 | CN1524579A Composite viscoelastic preparation |
| 09/01/2004 | CN1524578A Dry heat processing stabilizer for prothrombin complex or factor v a IX preparation |
| 09/01/2004 | CN1524577A Alkaline fibroblast growth factor pellicle and its production method |
| 09/01/2004 | CN1524576A Composite thymus peptide with immunoregulation function |
| 09/01/2004 | CN1524575A Virulence genes and proteins, and their use |
| 09/01/2004 | CN1524574A Oral medicament of viral infection preventing agent |
| 09/01/2004 | CN1524573A Ossotide sodium chloride injection and its preparing process |
| 09/01/2004 | CN1524516A Glicetin -1 slow release microspheric preparation and its use |
| 09/01/2004 | CN1164761C Process for producing product contg. antihypertensive tripeptides |
| 09/01/2004 | CN1164760C Tenascin-C nucleic acid ligands |
| 09/01/2004 | CN1164757C Method for reproducing fly maggot with transgenic antibacterial peptide |
| 09/01/2004 | CN1164744C Preparing process of modification enzyme for earthworm fibrinolysin |
| 09/01/2004 | CN1164675C Polymeric composition for solubilizing poorly water soluble drugs and process for preparation thereof |
| 09/01/2004 | CN1164614C Memory clearing protein and its application |
| 09/01/2004 | CN1164611C Synthesizing method for propyl-glutdipeptide |
| 09/01/2004 | CN1164338C Process for preparing nm-phase calcium-phosphorus salt/collagen/high-molecular bone compounded porous material |
| 09/01/2004 | CN1164334C Sustained release formulation of peptide |
| 09/01/2004 | CN1164333C Recombinant basic fibroblast growth factor protection agent |
| 09/01/2004 | CN1164329C Thrombase capable of carrying about and its preparation method |
| 09/01/2004 | CN1164328C IL6RIL6 chimera for treatment of neurodegenerative diseases |
| 09/01/2004 | CN1164327C Use of endothelium chalone in preparation of eye medicament |
| 09/01/2004 | CN1164326C Deoxidation type glutathione lozenge |
| 08/31/2004 | US6784335 Targeting construct comprising first and second polynucleotide sequences homologous to a bmp gene, and a selectable marker; animal models; bone morphogenetic proteins (bmp) |
| 08/31/2004 | US6784291 Splice-region antisense composition and method |
| 08/31/2004 | US6784290 Antisense oligonucleotide inhibition of ras |
| 08/31/2004 | US6784283 Peptide antibiotics |
| 08/31/2004 | US6784164 Choline binding proteins for anti-pneumococcal vaccines |
| 08/31/2004 | US6784163 Inhibition of cationic amino acid transporter protein and uses thereof |
| 08/31/2004 | US6784162 Replacement lipoprotein lipase gene is expressed in the individual to produce a functional lipoprotein lipase enzyme |
| 08/31/2004 | US6784161 Method for the treatment or prevention of flavivirus infections using nucleoside analogues |
| 08/31/2004 | US6784157 Peptide activates dna binding of wild-type p53 or a p53 mutant containing a single amino acid substitution; a peptidomimetic consisting of four sequential amino acids from a negative regulatory region; anticarcinogenic, -tumor agents |
| 08/31/2004 | US6784156 Cyclosporins for the treatment of respiratory diseases |
| 08/31/2004 | US6784155 Contacting hematopoietic cells with a stem cell proliferation stimulating amount of inprol or an opiate compound or a combination of inprol and an opiate compound |
| 08/31/2004 | US6784154 Method of use of erythropoietin to treat ischemic acute renal failure |
| 08/31/2004 | US6784153 Identify molecules that can bind to organ or tissue specific markers and, therefore, can home to the organ or tissue; membrane dipeptidase (mdp)-binding homing molecule, which is a molecule that selectively homes to lung endothelium |
| 08/31/2004 | US6783981 Capable of delivering anti-viral inhibitory rna molecules to target cells; gene therapy |
| 08/31/2004 | US6783979 Mink-related peptide 1 (mirp1), hyperpolarization-activated cyclic nucleotide (hcn); for assaying drug effects on heart rate |
| 08/31/2004 | US6783977 Internal ribosome entry site and vector containing same |
| 08/31/2004 | US6783973 For in vitro agonist and antagonist screening |
| 08/31/2004 | US6783965 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/31/2004 | US6783960 Polypeptide for use in the treatment of thrombosis and sepsis |
| 08/31/2004 | US6783959 Cd antigens for diagnosis/therapy |
| 08/31/2004 | US6783956 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 08/31/2004 | US6783955 Polynucleotides encoding human presenilin variant |
| 08/31/2004 | US6783954 VEGF nucleic acid and amino acid sequences |
| 08/31/2004 | US6783953 For prevention and treatment of angiogenesis |
| 08/31/2004 | US6783952 Deleting portion of eukaryotic nucleotide sequence encoding cerebral cortical voltage-dependent calcium channel alpha 2 subunit yielding soluble secreted protein retaining affinity for (3h)gabapentin |
| 08/31/2004 | US6783931 Amine-derivatized nucleosides and oligonucleosides |
| 08/31/2004 | US6783930 Development of novel anti-microbial agents based on bacteriophage genomics |
| 08/31/2004 | US6783775 Comprising ceruloplasmin and a serum-derived composition (sdf) having a low molecular weight, electrically charged at acidic ph and having absorption at 280 mn, capable of inducing terminal cell differentiation of leukemic cells |
| 08/31/2004 | US6783763 Polyepitopic proteinic fragments of the E6 and E7 HPV proteins, production and use thereof in vaccines |
| 08/31/2004 | US6783759 Compositions and methods for modulating variola virus |
| 08/31/2004 | US6783758 Diagnosis and treatment of malignant neoplasms |
| 08/31/2004 | US6783757 Composition and method for increasing exorphin catabolism to treat autism |
| 08/31/2004 | US6782891 Process for the isolation of a major harmful oxidant from cigarette smoke |
| 08/31/2004 | CA2319150C .alpha.-ketoamide inhibitors of 20s proteasome |
| 08/31/2004 | CA2194369C Methods and compositions for the specific coagulation of vasculature |
| 08/27/2004 | CA2458001A1 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 08/26/2004 | WO2004072651A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 1f receptor (5-ht1f) |
| 08/26/2004 | WO2004072641A1 Compositions and methods for enhancing apoptosis |
| 08/26/2004 | WO2004072305A2 Atlastin |
| 08/26/2004 | WO2004072296A2 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | WO2004072293A2 Oligonucleotides which inhibit the expression of the ob-rgrp protein and method for detection of compounds modifying the interaction between the proteins of the ob-rgrp family and the leptin receptor |
| 08/26/2004 | WO2004072287A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | WO2004072284A1 Modulation of insulin like growth factor i receptor expression |
| 08/26/2004 | WO2004072282A1 Nephropathy-associated gene |
| 08/26/2004 | WO2004072275A2 Diagnosis and treatment of multiple sulfatase deficiency and other using a formylglycine generating enzyme (fge) |
| 08/26/2004 | WO2004072269A2 Bex4 nucleic acids, polypeptides, and method of using |
| 08/26/2004 | WO2004072265A2 Methods for monitoring drug activities in vivo |
| 08/26/2004 | WO2004072263A2 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | WO2004072262A2 Cultured cd14+ antigen presenting cells |
| 08/26/2004 | WO2004072243A2 Macrocyclic hepatitis c serine protease inhibitors |
| 08/26/2004 | WO2004072242A2 Screening of compounds for hematological disorder treatment |
| 08/26/2004 | WO2004072241A2 Compositions and methods for cleaving iap |
| 08/26/2004 | WO2004072240A2 Antiplasmin cleaving enzyme |
| 08/26/2004 | WO2004072111A2 Novel therapeutic and diagnostic apoptotic inductors |
| 08/26/2004 | WO2004072108A1 Cyclosporins for the treatment of immune disorders |
| 08/26/2004 | WO2004072105A2 Iap-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods |
| 08/26/2004 | WO2004072100A2 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | WO2004072099A2 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41 |
| 08/26/2004 | WO2004072096A2 Peptides binding gp120 of hiv-1 |
| 08/26/2004 | WO2004072095A2 Cyclized peptides as exotoxin antagonists |
| 08/26/2004 | WO2004072093A2 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 08/26/2004 | WO2004071571A1 Methods for the purification of stable radioiodine conjugates |
| 08/26/2004 | WO2004071528A1 Inhibition of the cd95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 08/26/2004 | WO2004071526A1 Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof |
| 08/26/2004 | WO2004071525A1 Methods for treating mammary gland disorders |
| 08/26/2004 | WO2004071524A1 Albumin solution and method for the production thereof |
| 08/26/2004 | WO2004071523A1 Stem cell factor for preventing chemotherapy-induced depletion of blood cells |
| 08/26/2004 | WO2004071522A1 New pharmaceutical compositions based on anticholinergics and soluble tnf receptor fusion proteins |
| 08/26/2004 | WO2004071521A1 The use of lupin conglutin for the treatment of type ii diabetes |
| 08/26/2004 | WO2004071517A2 Uses of il-23 related reagents |
| 08/26/2004 | WO2004071510A1 Pharmaceutical composition comprising immunosuppressants for the treatment of dermatophytosis |
| 08/26/2004 | WO2004071500A1 Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof |